All Stories

  1. Forensic DNA phenotyping in Europe: views “on the ground” from those who have a professional stake in the technology
  2. The “We” in the “Me”
  3. Book review
  4. Participatory medicine
  5. Participants' and patients' access to raw data in biobanks
  6. Ready to Put Metadata on the Post-2015 Development Agenda? Linking Data Publications to Responsible Innovation and Science Diplomacy
  7. Opening Pandora’s box in the UK: a hypothetical pharmacogenetic test for clozapine
  8. Solidarität
  9. Online health platforms
  10. Studying the regulation of biotechnology and bioscience
  11. Beyond-the-clinic (BTC) genetics: The case of pharmacogenomics
  12. The Prüm Treaty: Transnational bioinformation exchange in Europe
  13. Wer fürchtet sich vor dem Prothesenchromosom?
  14. Genetic Indeterminism of Social Action
  15. Citizen Science in Health Domain
  16. DTC online genetics in Germany
  17. Direct-to-consumer theranostics, 21st century collective innovation and entrepreneurship
  18. Risky profiles: societal dimensions of forensic uses of DNA profiling technologies
  19. The future of technologies for personalised medicine
  20. SOLIDARITY IN CONTEMPORARY BIOETHICS – TOWARDS A NEW APPROACH
  21. Solidarity. Reflections on an Emerging Concept in Bioethics. Summary
  22. Elias G. Carayannis and David F. J. Campbell, Mode 3 Knowledge Production in Quadruple Helix Innovation Systems: 21st-Century Democracy, Innovation, and Entrepreneurship for Development
  23. Bracketing off population does not advance ethical reflection on EVCs: A reply to Kayser and Schneider
  24. Overcoming embryonic exceptionalism? Lessons from analyzing human stem cell research regulation in Israel
  25. James F. Drane: A Liberal Catholic Bioethics. Muenster, DE: Lit Verlag. 2010, 290 Pages
  26. Voting with their Mice: Personal Genome Testing and the “Participatory Turn” in Disease Research
  27. Enterprising or altruistic selves? Making up research subjects in genetics research
  28. A Survey of UK Public Interest in Internet-Based Personal Genome Testing
  29. Genetic Suspects
  30. Key issues in DNA profiling and databasing: implications for governance
  31. Partners in crime: the use of forensic DNA technologies in Austria
  32. How do we collaborate? Social science researchers’ experience of multidisciplinarity in biomedical settings
  33. Direct-to-consumer genome testing: opportunities for pharmacogenomics research?
  34. Die Verflüssigung der Norm: Selbstregierung und personalisierte Gesundheit
  35. Book Reviews
  36. Separating The Social From the Natural
  37. Attitudes of social science students in Israel and Austria towards the Belated Twins scenario—an exploratory study
  38. Being a member of the club: the transnational (self-)governance of networks of biobanks
  39. Stem Cell Technologies 1998–2008: Controversies and Silences
  40. Clean Soil and Common Ground: The Biopolitics of Human Embryonic Stem Cell Research in Austria
  41. Book review
  42. The regulation of DTC genetics
  43. What are the stakes? Genetic nondiscrimination legislation and personal genomics
  44. An Austrian Perspective
  45. Stem Cell Stories 1998–2008
  46. ‘Private fears in public places?’ Ethical and regulatory concerns regarding human genomic databases
  47. Research populations: biobanks in Israel
  48. Twins: A cloning experience
  49. Emotion in political discourse: contrasting approaches to stem cell governance in the USA, UK, Israel and Germany
  50. Relocating health governance: personalized medicine in times of 'global genes
  51. The Rise of Genetic Couplehood? A Comparative View of Premarital Genetic Testing
  52. ‘Science for survival’: biotechnology regulation in Israel
  53. Genetically modified survival: Red and green biotechnology in Israel
  54. Streitbare Zellen? Die Politik der Bioethik in Israel
  55. Religion, Bio-Medizin und Politik
  56. DIY Genetics: The right to know your own genome